surmount-1 tirzepatide weight loss percent 72 weeks reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism The results are finally in

Author HealthCert Education As GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) become more widely prescribed for type 2 diabetes and weight management, general practitioners are increasingly likely to encounter patients experiencing gut-related side effects

Semaglutide is a GLP-1 receptorbased therapy that works through pathways involved in appetite regulation, digestion, and glucose metabolism

SingleCare Blog

Taking too much Ozempic can have serious consequences for ones health

TD1 usually occurs acutely unless it is a continuation of TD2

The peptide represents a modified version of the 176-191 amino acid sequence from growth hormones C-terminal region, with a tyrosine addition at the N-terminus for stability